News
Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...
Earendil Labs, an expert in AI-driven research and development of next-generation biologics therapeutics, and Sanofi have ...
Vietnam Investment Review on MSN2d
Earendil Labs Sanofi Ink Global License Deal for Next Gen Autoimmune TherapiesEarendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and Sanofi today announced that they have entered into a license agreement for two ...
Sanofi CEO Paul Hudson was among seven top business officials from different countries who spoke at the meeting, according to state news agency Xinhua (Chinese). The French pharma in December made ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
Pharmaceutical Technology on MSN20d
Sanofi’s Qfitlia approved by FDA as first haemophilia therapy for all patientsDespite a haemophilia market bustling with rivals, Qfitlia’s broad label and favourable dosing regimen could give it an upper hand.
Along with Le Fur – who was CEO at Sanofi predecessor Sanofi-Aventis in 2007 and 2008 – eureKING's backers include Michael Kloss, former head of Panasonic Healthcare, who will serve as CEO of ...
MedPage Today on MSN2d
FDA Approves New Option for Chronic HivesThe FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...
Robert is currently chief digital officer at the cruise line firm Viking Cruises and will join Sanofi on 15th June. His brief is to drive Sanofi’s digital, data and technology strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback